News

A group of international scientists have completed the first global inventory of flu strains in birds by reviewing more than 50 published studies and genetic data, providing new insight into the drivers of viral diversity and the emergence of disease that can ultimately impact human health and livelihoods.

University of Pennsylvania researchers have successfully genetically engineered the immune cells of 12 HIV positive patients to resist infection, and decreased the viral loads of some patients taken off antiretroviral drug therapy (ADT) entirely-including one patient whose levels became undetectable. The study, appearing today in the New England Journal of Medicine, is the first published report of any gene editing approach in humans.

Increased investment in research and development for new vaccines is key to halting the spread of genital herpes, gonorrhea, chlamydia, syphilis and trichomoniasis, according to a new special issue of the journal Vaccine, co-edited by the World Health Organization (WHO) and the United States’ National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Health (NIH).